CVE-2026-62217OpenClaw 2026.5.14-beta.1 before 2026.5.27 contain an authorization flaw in the QQBot exec approvals feature.
Updated under an hour ago ()
Does this affect you?
It affects openclaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OpenClaw 2026.5.14-beta.1 before 2026.5.27 contain an authorization flaw in the QQBot exec approvals feature. When the feature is enabled and reachable, a lower-trust caller or configured input path could execute or persist actions beyond the caller's intended authorization, allowing non-allowlisted senders to perform unauthorized operations.
- CVSS
- 8.8 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-863
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jul 21, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
openclaw openclaw openclaw:openclaw | from 2026.5.14 before 2026.5.27 | NVD |
References
- https://github.com/openclaw/openclaw/security/advisories/GHSA-7jx6-764p-fgg9vendor-advisory
- https://www.vulncheck.com/advisories/openclaw-beta-1-authentication-bypass-via-exec-approvalsthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.